1–10 of 61 results for Epiretinal Membrane
Impact of Faricimab vs Aflibercept on Epiretinal Membrane Formation Over 2 Years in Eyes With DME in the YOSEMITE/RHINE Phase 3 Trials
Glenn J. Jaffe, MD
Annual Meeting Talks
2023
Clinical Characteristics of Full-Thickness Macular Holes That Closed Without Surgery
J. Fernando Arevalo, MD, PhD, FACS, FASRS
Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy Associated with Rhegmatogenous Retinal Detachment: The Phase II FIXER Trial
Ayman Elnahry, MD, PhD
Expert Panel: PVR
Christina Y Weng, MD, MBA, FASRS
Lejla Vajzovic, MD, FASRS
Isabela Martins Melo, MD
Sarah Syeda, MD
Prashant Keshao Bawankule, M.S.
Leo A. Kim, MD, PhD
2024
Expert Panel: Myopic Traction Maculopathy
Carl C. Awh, MD, FASRS
Taku Wakabayashi, MD, PhD
Sengul Ozdek, MD, FEBO, FASRS
Nikoloz Labauri, MD, FVRS
Gabriela Lopezcarasa Hernandez, MD
Medical Case Conference: Scott Walter, MD, MSc, FASRS
Scott D Walter, MD, MSc, FASRS
Epiretinal Membrane and Cystoid Macular Edema Following Vitrectomy and Encircling Endolaser Photocoagulation for Retinal Detachment
Homayoun Tabandeh, MD, FASRS
Retinal Detachment and Epiretinal Membrane Development in Fellow-Eye Laser Prophylaxis
Bradley T. Smith, MD, FASRS
Risk Factors for Severe Epiretinal Membrane Formation after Repair of Rhegmatogenous Retinal Detachments
Sally S Ong, MD
Surgical Retina Video Learning Library
2025
Nasal Crowding and Nasal Tilting of the Macula After Epiretinal Membrane Surgery
Kyu Hyung Park, MD
2022